Evogene Ltd
EVGN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.35M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.35 Million |
|---|---|
| Enterprise Value | $-2,876,082.00 |
| Earnings per Share | $-1.08 |
| Beta | 0.72 |
| Outstanding Shares | 12,199,883 |
Return
| Return on Equity | 335.26% |
|---|---|
| Return on Assets | -82.07% |
| Return on Invested Capital | -203.83% |
Valuation & Multiples
| P/E Ratio | -0.4 |
|---|---|
| PEG | 0.67 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.58 |
| Enterprise Value to EBIT | -0.13 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.76 |
| Debt to Equity | -0.64 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$-0.27
Consensus analyst estimateRevenue Estimate
$325,000
Consensus analyst estimateNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-0.19
Consensus analyst estimateRevenue Estimate
$365,000
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Evogene Ltd
52 employees
CEO: Ofer Haviv
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, I...